Today on TAP: Its coverage is often biased and sloppy.
Medicare
Posted inHealth and Social Policy
Merck Says Negotiating Drug Prices Is Unconstitutional
The Inflation Reduction Act took minor steps against Big Pharma price-gouging. Merck is outraged.
Posted inHealth and Social Policy
So Long but Not Farewell to Envision
The private equity–owned ER doctor practice, now headed to bankruptcy, was one of the defining companies of 21st-century American medicine.
Posted inHealth and Social Policy
Regulators on the Verge of Bungling Drug Price Reform, Advocates Say
The starting point for negotiations with drug companies on prescription prices could end up being the too-high prices patients already live with.
Posted inHealth and Social Policy
Born to Die
Medicare spends tens of billions of dollars on hospice care each year. A new report ponders why regulators insist on going easy on literal death merchants.
Posted inHealth and Social Policy
Insurance Lobbyists Force Government to Heel on Medicare Advantage
But advocates see an opening for reining in the worst abuses of the program.
Posted inHealth and Social Policy
California Goes In for Drugmaking
The state will make and distribute insulin at cost. That should be a model for every other state.
Posted inHealth and Social Policy
The Fight for Mental Health Parity
The expiration of the COVID public-health emergency will make it harder to obtain treatment. But hurdles already existed in the law.
Posted inTAP
A Small Victory Over Big Pharma
Today on TAP: Eli Lilly announces insulin price caps, but keep an eye on the footnotes.